FOS1 and SP1 are also enriched for binding within MPP2 cCRE regions and were predicted to have enhanced binding to this PD risk-associated allele, as was ZNF219, an important regulator of SNCA expression [65]. This evidence concerns the gene SP1 and Parkinson disease.